Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-073798
Filing Date
2025-08-04
Accepted
2025-08-04 20:53:40
Documents
1
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2522414-15_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2522414-15_4seq1.xml 4 12933
  Complete submission text file 0001104659-25-073798.txt   14560
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
Hussain Abbas (Reporting) CIK: 0001821956 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 251182463